Participants in study 1 included 60 with pulmonary TB and HIV coinfection, 40 with CD4 counts of >200 cells/mm3, and 20 with CD4 counts of <200 cells/mm3, as well as 20 participants living with HIV and without TB (who contributed only genotype data). The gene discussed is CD4; the disease is tuberculosis.